185 related articles for article (PubMed ID: 17476480)
1. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.
Jager G; de Win MM; Vervaeke HK; Schilt T; Kahn RS; van den Brink W; van Ree JM; Ramsey NF
Psychopharmacology (Berl); 2007 Aug; 193(3):403-14. PubMed ID: 17476480
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.
de Win MM; Reneman L; Jager G; Vlieger EJ; Olabarriaga SD; Lavini C; Bisschops I; Majoie CB; Booij J; den Heeten GJ; van den Brink W
Neuropsychopharmacology; 2007 Feb; 32(2):458-70. PubMed ID: 17077812
[TBL] [Abstract][Full Text] [Related]
3. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.
Jager G; de Win MM; van der Tweel I; Schilt T; Kahn RS; van den Brink W; van Ree JM; Ramsey NF
Neuropsychopharmacology; 2008 Jan; 33(2):247-58. PubMed ID: 17460617
[TBL] [Abstract][Full Text] [Related]
5. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
[TBL] [Abstract][Full Text] [Related]
6. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
Rodgers J; Buchanan T; Scholey AB; Heffernan TM; Ling J; Parrott AC
J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
[TBL] [Abstract][Full Text] [Related]
7. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
[TBL] [Abstract][Full Text] [Related]
8. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
9. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
[TBL] [Abstract][Full Text] [Related]
11. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
[TBL] [Abstract][Full Text] [Related]
12. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Daumann J; Fischermann T; Heekeren K; Henke K; Thron A; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2005 Aug; 180(4):607-11. PubMed ID: 15372137
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
14. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.
De Win MM; Jager G; Vervaeke HK; Schilt T; Reneman L; Booij J; Verhulst FC; Den Heeten GJ; Ramsey NF; Korf DJ; Van den Brink W
Int J Methods Psychiatr Res; 2005; 14(4):167-85. PubMed ID: 16395871
[TBL] [Abstract][Full Text] [Related]
15. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
[TBL] [Abstract][Full Text] [Related]
16. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
17. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E
Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evidence of hippocampal damage in chronic users of ecstasy.
den Hollander B; Schouw M; Groot P; Huisman H; Caan M; Barkhof F; Reneman L
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):83-5. PubMed ID: 21444322
[TBL] [Abstract][Full Text] [Related]
19. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Fox HC; Parrott AC; Turner JJ
J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
